Evidence map›Paper›PMID 37003679›Full record

ReviewCardiology clinics2023

Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis.

Anam Waheed, Sharmila Dorbala

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cardiology clinics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anam WaheedDivision of Cardiovascular Imaging, Department of Radiology, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Sharmila DorbalaDivision of Cardiovascular Imaging, Department of Radiology, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA; Cardiac Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address: sdorbala@bwh.harvard.edu.

Funding

Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late LifeR01HL150342 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DORBALA, SHARMILA, SHAH, AMIL M · 2020 to 2023
$4.1M
Molecular Imaging of Primary Amyloid CardiomyopathyR01HL130563 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DORBALA, SHARMILA, FALK, RODNEY H · 2016 to 2019
$3.3M
NHLBI NIH HHS R01 HL130563NHLBI NIH HHS R01 HL150342
6 · The paper itself

Abstract

Cardiac single photon emission computed tomography using

Indexed as

AmyloidosisCardiomyopathiesHeartHumansPrealbuminRadionuclide ImagingRadiopharmaceuticalsPrealbuminRadiopharmaceuticals(99m)Tc-DPD(99m)Tc-HDP(99m)Tc-PYPBone avid tracer cardiac scintigraphyCardiac amyloidosisSingle photon emission computed tomographyTransthyretin cardiac amyloidosis

Identifiers

PMID37003679
PMCPMC11140431

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.